← USPTO Patent Grants

Kits and methods for induction of cardioversion in subjects with atrial arrhythmias

Grant US12576074B2 Kind: B2 Mar 17, 2026

Assignee

InCarda Therapeutics, Inc.

Inventors

Luiz Belardinelli, Carlos Schuler, Miguel Guzman

Abstract

Disclosed herein are methods and kits for treating or preventing a heart condition, e.g., cardiac arrhythmia, e.g., atrial arrhythmia, using potassium channel inhibitors and class I antiarrhythmic agents. Also disclosed herein are methods and kits for treating a heart condition via an intravenously, orally, or inhalationally administered fixed-dose combination of a sodium channel blocker and a class I antiarrhythmic agent.

CPC Classifications

A61K 31/4458 A61K 31/18 A61K 31/167 A61K 31/138 A61P 9/06

Filing Date

2023-03-20

Application No.

18186668

Claims

24